Vitamin Agonists

Featured Inhibitors
Inhibitors (2)
Chemicals (42)
Agonists (2)
Activator (1)
Antagonists (4)

Cat.No.	Product Name	Information	Product Use Citations	Product Validations
S6681	Paricalcitol	Paricalcitol is a selective vitamin D receptor agonist. This compound suppresses parathyroid hormone mRNA expression and inhibits parathyroid cell proliferation. It is used to treat secondary hyperparathyroidism in chronic kidney disease.	Redox Biol, 2025, 80:103518 Redox Biol, 2024, 70:103062 Front Pharmacol, 2024, 15:1421577
S1466	Calcitriol (1,25-Dihydroxyvitamin D3)	Calcitriol is a nonselective vitamin D receptor activator/agonist(VDRA), exhibiting a 10-fold higher vitamin D receptor (VDR) binding affinity(IC50=0.4 nM) than the selective VDRA paricalcitol. Solutions are unstable and should be fresh-prepared.	Anticancer Research, June 2021, 2945-2952 bioRxiv, February 08, 2024, nan Cells, August 20, 2021, 2149

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

S6681

Paricalcitol

Paricalcitol is a selective vitamin D receptor agonist. This compound suppresses parathyroid hormone mRNA expression and inhibits parathyroid cell proliferation. It is used to treat secondary hyperparathyroidism in chronic kidney disease.

Redox Biol, 2025, 80:103518

Redox Biol, 2024, 70:103062

Front Pharmacol, 2024, 15:1421577

S1466

Calcitriol (1,25-Dihydroxyvitamin D3)

Calcitriol is a nonselective vitamin D receptor activator/agonist(VDRA), exhibiting a 10-fold higher vitamin D receptor (VDR) binding affinity(IC50=0.4 nM) than the selective VDRA paricalcitol. Solutions are unstable and should be fresh-prepared.

Anticancer Research, June 2021, 2945-2952

bioRxiv, February 08, 2024, nan

Cells, August 20, 2021, 2149

Verified customer review of Calcitriol (1,25-Dihydroxyvitamin D3)